hydrazine has been researched along with Bone Cancer in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Brohl, AS; Cubitt, CL; Fridley, B; Kahen, E; Reed, DR; Welch, D | 1 |
| Amatruda, JF; Arrigoni, C; Baldauf, MC; Bardinet, V; Cidre-Aranaz, F; Colombo, MV; Cossarizza, A; Dallmayer, M; Gerke, JS; Grünewald, TGP; Henssen, AG; Hölting, TLB; Kirchner, T; Knott, MML; Li, J; Marchetto, A; Moretti, M; Musa, J; Ohmura, S; Orth, MF; Romero-Pérez, L; Sannino, G; Saucier, D; Stein, S; Wehweck, FS | 1 |
| Argenziano, M; Di Martino, M; Di Paola, A; Di Pinto, D; Perrotta, S; Pota, E; Punzo, F; Rossi, F; Tortora, C | 1 |
| Depping, R; Dunst, J; Kosyna, FK; Landesman, Y; Mandl, M; von Fallois, M | 1 |
| Arnold, MA; Bid, HK; Brandolini, L; Cam, H; Cam, M; Gross, AC; Hinckley, JM; Houghton, PJ; London, CA; Mo, X; Phelps, DA; Roberts, RD; Saraf, AJ; Winget, SA | 1 |
| Dai, EN; Li, JM; Liu, B; Tian, JX; Xu, L | 1 |
| Liu, W; Ma, N; Niu, JC; Wang, PJ | 1 |
| Baloglu, E; Cao, Q; Chu, P; Doan, N; Forscher, C; Gery, S; Guo, X; Koeffler, HP; Lee, VK; Lim, HJ; Lin, DC; Marijon, H; Mayakonda, A; Pang, B; Rajalingam, R; Said, JW; Shacham, S; Sun, H; Thomas, T; Xu, L; Yang, H; Zhao, Z | 1 |
| Aboukameel, A; Argueta, C; Azmi, AS; Drolen, C; Kashyap, T; Kauffman, M; Klebanov, B; Landesman, Y; Lee, M; Mohammad, RM; Muqbil, I; Senapedis, W; Shacham, S; Unger, TJ | 1 |
| Colella, S; Johnson, MM; Krahe, R; Mora, E; Simeone, AM; Tari, AM | 1 |
| Benjamin, T; Ward, JM; Weisburger, JH; Yamamoto, RS | 1 |
11 other study(ies) available for hydrazine and Bone Cancer
| Article | Year |
|---|---|
Small molecule inhibition of lysine-specific demethylase 1 (LSD1) and histone deacetylase (HDAC) alone and in combination in Ewing sarcoma cell lines.
Topics: Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Cyclophosphamide; Depsipeptides; Doxorubicin; Drug Synergism; Drug Therapy, Combination; Etoposide; Histone Deacetylase Inhibitors; Histone Deacetylases; Histone Demethylases; Humans; Hydrazines; Irinotecan; Sarcoma, Ewing; Sulfonamides; Vincristine | 2019 |
Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma.
Topics: Adult; Animals; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Child; Chondrocytes; DNA Methylation; Enhancer Elements, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Hydrazines; Mesenchymal Stem Cells; Mice; Microsatellite Repeats; Mitochondria; Oligonucleotide Array Sequence Analysis; Oncogene Proteins, Fusion; Oncogenes; Oxidative Stress; RNA Interference; Sarcoma; Sarcoma, Ewing; SOXD Transcription Factors | 2020 |
Effects of Iron Chelation in Osteosarcoma.
Topics: Apoptosis; Benzoates; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deferasirox; Drug Therapy, Combination; Humans; Hydrazines; Iron Chelating Agents; Osteosarcoma; Pyrazoles; Treatment Outcome | 2021 |
Selinexor decreases HIF-1α via inhibition of CRM1 in human osteosarcoma and hepatoma cells associated with an increased radiosensitivity.
Topics: Apoptosis; Bone Neoplasms; Carcinoma, Hepatocellular; Cell Proliferation; Exportin 1 Protein; Gene Expression Regulation, Neoplastic; Humans; Hydrazines; Hypoxia-Inducible Factor 1, alpha Subunit; Karyopherins; Liver Neoplasms; Osteosarcoma; Radiation Tolerance; Radiation-Sensitizing Agents; Receptors, Cytoplasmic and Nuclear; Triazoles; Tumor Cells, Cultured | 2021 |
IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis.
Topics: Adolescent; Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Child; Cytokine Receptor gp130; Drug Evaluation, Preclinical; Follow-Up Studies; Humans; Hydrazines; Interleukin-6; Interleukin-8; Lung; Lung Neoplasms; Male; Mice; Osteosarcoma; Primary Cell Culture; Quinoxalines; Receptors, Interleukin-8A; Sulfonamides; Xenograft Model Antitumor Assays; Young Adult | 2018 |
Anti-tumoral potential of MDA19 in human osteosarcoma via suppressing PI3K/Akt/mTOR signaling pathway.
Topics: Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Hydrazines; Indoles; Osteosarcoma; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases | 2018 |
EP1 receptor is involved in prostaglandin E2-induced osteosarcoma growth.
Topics: Animals; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dinoprostone; Gene Silencing; Humans; Hydrazines; Mice; Mice, Nude; Osteosarcoma; Oxazepines; Receptors, Prostaglandin E, EP1 Subtype; Xenograft Model Antitumor Assays | 2019 |
CRM1 Inhibition Promotes Cytotoxicity in Ewing Sarcoma Cells by Repressing EWS-FLI1-Dependent IGF-1 Signaling.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Survival; Drug Synergism; Exportin 1 Protein; Female; Gene Knockdown Techniques; Humans; Hydrazines; Imidazoles; Immunoblotting; Immunohistochemistry; Insulin-Like Growth Factor I; Karyopherins; Mice; Mice, Nude; Oncogene Proteins, Fusion; Proto-Oncogene Protein c-fli-1; Pyrazines; Real-Time Polymerase Chain Reaction; Receptors, Cytoplasmic and Nuclear; RNA-Binding Protein EWS; Sarcoma, Ewing; Signal Transduction; Triazoles; Xenograft Model Antitumor Assays | 2016 |
Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell death.
Topics: Active Transport, Cell Nucleus; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bortezomib; Cell Death; Cell Line, Tumor; Cell Nucleus; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Exportin 1 Protein; Female; Fibrosarcoma; Humans; Hydrazines; Karyopherins; Mice, Inbred ICR; Mice, SCID; NF-kappa B; NF-KappaB Inhibitor alpha; Osteosarcoma; Phosphorylation; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Proteolysis; Receptors, Cytoplasmic and Nuclear; RNA Interference; Signal Transduction; Time Factors; Transcription Factor RelA; Transfection; Triazoles | 2016 |
N-(4-Hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cells.
Topics: Anticarcinogenic Agents; Apoptosis; Bone Neoplasms; Breast Neoplasms; Dose-Response Relationship, Drug; Enzyme Induction; Female; Fenretinide; Humans; Hydrazines; Neoplasm Invasiveness; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitrogen Oxides; Tumor Cells, Cultured | 2006 |
Transplantation of chemically induced metastatic mucinous adenocarcinomas of the jejunum and colon in rats.
Topics: Adenocarcinoma, Mucinous; Animals; Bone Neoplasms; Carcinogens; Colonic Neoplasms; Hydrazines; Intestinal Neoplasms; Jejunum; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasm Transplantation; Peritoneal Neoplasms; Pleural Neoplasms; Rats; Time Factors; Transplantation, Homologous | 1973 |